Status | Study |
Recruiting |
Study Name: Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency Condition: Factor VII Deficiency Date: 2017-03-04 Interventions: Biological: Eptacog alfa, biosimilar and reference medicinal product Novosev |
Completed |
Study Name: Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency Condition: Congenital Coagulation Factor VII Deficiency Date: 2015-06-10 Interventions: Biological: Eptacog alfa (activated) or pdFVII |
Completed |
Study Name: Treatment of Congenital Factor VII Deficiency Condition: Congenital Bleeding Disorder Congenital FVII Deficiency Date: 2013-01-15 Interventions: Drug: activated recombinant human factor VII |
Completed |
Study Name: Treatment of Inherited Factor VII Deficiency Condition: Factor VII Deficiency Date: 2010-12-17 Interventions: Drug: plasma derived Factor VII |